Follow
Mauricio Marquez Palencia, Ph.D.
Mauricio Marquez Palencia, Ph.D.
Verified email at utsouthwestern.edu
Title
Cited by
Cited by
Year
Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness
PK Parida, M Marquez-Palencia, V Nair, AK Kaushik, K Kim, J Sudderth, ...
Cell metabolism 34 (1), 90-105. e7, 2022
452022
Determinants of renal cell carcinoma invasion and metastatic competence
K Kim, Q Zhou, A Christie, C Stevens, Y Ma, O Onabolu, S Chintalapati, ...
Nature communications 12 (1), 5760, 2021
322021
Metastatic latency, a veiled threat
K Kim, M Marquez-Palencia, S Malladi
Frontiers in immunology 10, 472463, 2019
232019
Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastases
PK Parida, M Marquez-Palencia, S Ghosh, N Khandelwal, K Kim, V Nair, ...
Nature Cancer 4 (6), 893-907, 2023
92023
Cell competition shapes metastatic latency and relapse
K Kim, H Huang, PK Parida, L He, M Marquez-Palencia, TC Reese, ...
Cancer discovery 13 (1), 85-97, 2023
82023
Optimized protocol for stable isotope tracing and steady-state metabolomics in mouse HER2+ breast cancer brain metastasis
PK Parida, M Marquez-Palencia, AK Kaushik, K Kim, V Nair, J Sudderth, ...
STAR protocols 3 (2), 101345, 2022
12022
AXL/WRNIP1 mediates replication stress response and promotes therapy resistance and metachronous metastasis in HER2+ breast cancer
M Marquez-Palencia, L Reza Herrera, PK Parida, S Ghosh, K Kim, ...
Cancer Research 84 (5), 675-687, 2024
2024
AXL-WRNIP1 mediated replication stress response aids metastatic latency and relapse
M Marquez-Palencia, S Malladi
Cancer Research 83 (7_Supplement), 2462-2462, 2023
2023
Abstract PD4-07: Targeting latent residual HER2+ breast cancer brain metastatic cells
M Marquez-Palencia, S Malladi
Cancer Research 82 (4_Supplement), PD4-07-PD4-07, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–9